Clinical Research Directory
Browse clinical research sites, groups, and studies.
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
Sponsor: Loreen Herwaldt
Summary
The purpose of this study is to see whether applying povidone iodine (PVI) to the noses of patients undergoing lower extremity (leg, ankle, or foot) orthopedic fixation procedures of high-energy lower extremity fractures (HELEF) will decrease the patients' risk of surgical site infections (SSI), particularly those caused by Staphylococcus aureus.
Official title: Intranasal Povidone Iodine (PVI) to Prevent Staphylococcus Aureus Surgical Site Infections After Operative Procedures to Fix High-Energy Lower Extremity Fractures (POTENT Study)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2000
Start Date
2022-09-15
Completion Date
2026-05-31
Last Updated
2026-02-04
Healthy Volunteers
No
Conditions
Interventions
povidone-iodine topical ointment
Intranasal povidone-iodine will be applied to the lower anterior nares (i.e. nostril) of patients undergoing HELEF orthopedic repair.
Locations (6)
Emory University
Atlanta, Georgia, United States
University of Indiana
Indianapolis, Indiana, United States
University of Iowa
Iowa City, Iowa, United States
Washington University
St Louis, Missouri, United States
University of Texas Southwestern
Dallas, Texas, United States
University of Utah
Salt Lake City, Utah, United States